Lloyd Howell Jr. - 28 May 2025 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
30 May 2025, 17:57:16 UTC
Prior SEC filing
17 Mar 2025
Next SEC filing
09 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact

Key filing fact

Lloyd Howell Jr. filed Form 4 for GE HealthCare Technologies Inc. (GEHC) on 30 May 2025.

Key facts

  • This page summarizes Lloyd Howell Jr.'s Form 4 filing for GE HealthCare Technologies Inc. (GEHC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 30 May 2025, 17:57.

Change

  • Previous filing in this sequence was filed on 17 Mar 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001505488 Primary reporting owner

HOWELL LLOYD JR

Relationship
Director
Address
500 W. MONROE STREET, CHICAGO
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Signature date
30 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GEHC transaction

Common Stock, par value $0.01 per share

Award

Transaction value
$0
Shares
+3,092
Change %
+51%
Price
$0.000000
Shares after
9,116
Date
28 May 2025
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

Footnote F2

Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .